NCT03432559

Side Effects of Transesophageal Echocardiography

Completed NA Last updated 14 February 2018

What this trial tests

NA trial testing endoscopy in Upper Gastrointestinal Bleeding in 10 participants. Completed in 31 January 2018.

Timeline

1 July 2009

Primary endpoint
31 March 2010

31 January 2018

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	10
Start date	1 July 2009
Primary completion	31 March 2010
Estimated completion	31 January 2018
Sites	1 location across Austria

Drugs / interventions tested

• endoscopy

Conditions studied

• Upper Gastrointestinal Bleeding — all drugs for Upper Gastrointestinal Bleeding →

Sponsor

Medical University of Vienna

Who can join

18 and older, any sex, with Upper Gastrointestinal Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Transesophageal echocardiography is commonly used during cardiac surgery. Complications of transesophageal echocardiography are rare (1,2%), but are often underestimated and can lead to unrecognized blood loss and site of infection.

This study wants to assess the mucosa of pharynx, upper larynx, esophagus and stomach prior to and after echo probe insertion during cardiac surgery with endoscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.